|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-10-25
|
|
pubmed:abstractText |
Patients with pulmonary large cell neuroendocrine carcinoma (LCNEC) have a very poor prognosis, but the benefit of adjuvant chemotherapy for these patients has not been established. We performed a prospective analysis of adjuvant chemotherapy for patients with completely resected pulmonary LCNECs to assess the effect of adjuvant chemotherapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1552-6259
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
82
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1802-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:17062251-Aged,
pubmed-meshheading:17062251-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17062251-Carcinoma, Neuroendocrine,
pubmed-meshheading:17062251-Chemotherapy, Adjuvant,
pubmed-meshheading:17062251-Cisplatin,
pubmed-meshheading:17062251-Etoposide,
pubmed-meshheading:17062251-Female,
pubmed-meshheading:17062251-Humans,
pubmed-meshheading:17062251-Lung Neoplasms,
pubmed-meshheading:17062251-Male,
pubmed-meshheading:17062251-Middle Aged,
pubmed-meshheading:17062251-Pneumonectomy,
pubmed-meshheading:17062251-Prospective Studies,
pubmed-meshheading:17062251-Survival Analysis,
pubmed-meshheading:17062251-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma.
|
|
pubmed:affiliation |
Department of Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
